Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8246955 Substance specific to human PD-1

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
June 27, 2011
0
Date of Patent
August 21, 2012
0
Patent Application Number
13169278
0
Patent Citations Received
‌
US Patent 11685775 Method of increasing the ratio of effector T cells to regulatory T cells in a tumor by administering to a subject a TGF-beta inhibitor and a PD-1 antibody
0
‌
US Patent 11701357 Treatment of B cell cancers using a combination comprising Btk inhibitors
0
‌
US Patent 12006366 Methods and compositions for preventing type 1 diabetes
0
‌
US Patent 12091461 Bispecific antibody
0
‌
US Patent 11786529 Treatment of indolent or aggressive B-cell lymphomas using a combination comprising BTK inhibitors
Patent Inventor Names
Kazuhiko Takeda
0
Masakazu Miyamoto
0
Masayoshi Matsuo
0
Shiro Shibayama
0
Takao Yoshida
0
Tasuku Honjo
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
8246955
0
Patent Primary Examiner
‌
Ilia Ouspenski
0

Find more entities like US Patent 8246955 Substance specific to human PD-1

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo